MACI (matrix-induced autologous chondrocyte implant)
/ Vericel
- LARVOL DELTA
Home
Next
Prev
1 to 9
Of
9
Go to page
1
April 08, 2025
MASCOT: A Study of MACI in Patients Aged 17 to 65 Years With Symptomatic Chondral or Osteochondral Defects of the Ankle
(clinicaltrials.gov)
- P3 | N=276 | Not yet recruiting | Sponsor: Vericel Corporation
New P3 trial
July 03, 2023
PEAK: A Study of MACI in Patients Aged 10 to 17 Years With Symptomatic Chondral or Osteochondral Defects of the Knee
(clinicaltrials.gov)
- P3 | N=45 | Recruiting | Sponsor: Vericel Corporation | Trial completion date: Jun 2025 ➔ Jun 2027 | Trial primary completion date: Jun 2025 ➔ Jun 2027
Trial completion date • Trial primary completion date
January 07, 2021
"$VCEL Vericel Announces Expansion of MACI Coverage by UnitedHealthcare to Include Patella and Multiple Cartilage Defects in the Knee https://t.co/6soPUPh6Q0"
(@otcdynamics)
August 28, 2020
Use of MACI (Autologous Cultured Chondrocytes on Porcine Collagen Membrane) in the United States: Preliminary Experience.
(PubMed, Orthop J Sports Med)
- "Data were collected for 1000 consecutive patients starting on July 1, 2017, when Carticel (the prior generation of autologous cultured chondrocytes) was no longer available. Patient age and mean total MACI-treated defect size in the United States are similar to the findings of the pivotal European SUMMIT (Superiority of MACI Implant Versus Microfracture Treatment) trial and other studies from outside the United States. Treatment of multiple cartilage defects is more frequent in the United States than elsewhere."
Journal • Preclinical • Musculoskeletal Diseases
January 08, 2018
"$VCEL Dan Orlando discusses MACI product innovation with ABC7 @BloomTV #JPM18 highlights of hot technologies for 2018 @russopartners @VericelCorp @SolomonsWisdom"
(@davidschull)
Biosimilar
August 22, 2019
Demographics in Patients Receiving Matrix-Assisted Chondrocyte Implantation (MACI) in the Ankle.
(PubMed, Cartilage)
- "The sizes of treated defects followed the general recommendations. There were, however, significant differences between countries."
Clinical • Journal
July 23, 2019
"Representing @VericelCorp talking about #cartilage #MACI #jointpreservation for the #2019orthopaedicupdate meeting . Aloha!"
(@doccasslee)
January 29, 2019
"Team #MACI at #SBLIII Radio Row https://t.co/hKCp44ilve @VericelCorp @russopartners @SolomonsWisdom"
(@davidschull)
January 13, 2019
"We will see you on @atlsuperbowl53 #RadioRow with @VericelCorp Jan. 29-30 #SBLIII #ATL #MACI @russopartners"
(@davidschull)
1 to 9
Of
9
Go to page
1